- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Roche's Perjeta-based breast cancer regimen shows sustained survival benefits | ||
| Mi | Johnson & Johnson's bladder cancer therapy Balversa accepted by SMC | ||
| Mi | Eli Lilly's Zepbound shows superiority in head-to-head weight loss study | ||
| Di | Takeda's Adzynma approved by MHRA for rare blood clotting disorder cTTP | ||
| Di | AstraZeneca announces positive phase 3 results for Imfinzi in high-risk bladder cancer | ||
| Di | Novo Nordisk's Wegovy shows early protection against heart disease | ||
| Mo | FDA approves Verastem Oncology's combination therapy for rare ovarian cancer type | ||
| Mo | J&J/Protagonist's icotrokinra shows promise in difficult-to-treat plaque psoriasis | ||
| Mo | GSK shares promising phase 3 results for linerixibat in PBC-related itch | ||
| Fr | FDA announces rapid rollout of AI system to accelerate drug review process | ||
| Fr | BeiGene's Tevimbra combination granted EC approval in small cell lung cancer | ||
| Fr | Inizio Evoke appoints Tristen George and Kevin Kaniuga as executive creative directors | ||
| Fr | Apiary invests in life sciences performance marketing specialist performance-io | ||
| 08.05. | AstraZeneca/Daiichi Sankyo share positive phase 3 results for Enhertu in early breast cancer | ||
| 08.05. | Tiziana Life Sciences' intranasal MS candidate shows promise in open-label study | ||
| 08.05. | The Weber Shandwick Collective appoints Lucie Harper as president of Health, UK | ||
| 07.05. | Eli Lilly and Alchemab Therapeutics enter ALS agreement worth up to $415m | ||
| 07.05. | Johnson & Johnson shares long-term results for Tremfya in ulcerative colitis | ||
| 07.05. | MHRA approves Bavarian Nordic's chikungunya vaccine Vimkunya | ||
| 06.05. | AstraZeneca's Calquence approved by EC for first-line mantle cell lymphoma use | ||
| 06.05. | Bristol Myers Squibb's injectable Opdivo formulation granted MHRA for solid tumours | ||
| 06.05. | Alnylam's RNAi therapeutic vutrisiran recommended by CHMP for rare heart disease | ||
| 02.05. | Johnson & Johnson's Imaavy granted FDA approval for rare autoimmune disease gMG | ||
| 02.05. | NHS patients to access Theramex's endometriosis pill following NICE recommendation | ||
| 02.05. | AstraZeneca's triple-combination COPD therapy shows promise in uncontrolled asthma |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .